Loss of renal allografts secondary to Candida vascular complications in two recipients from the same donor.

Case Rep Transplant

Transplant Surgery Division, Department of Surgery, University of Nebraska Medical Center, Omaha, NE 68198-3285, USA.

Published: December 2012

Infections remain a major cause of morbidity and mortality in transplant patients. Organ recipients are also susceptible to donor-derived pathogens and the majority of donor infections are easily treatable. Rarely, some pathogens have produced life-threatening complications by compromising the vascular anastomosis. In this case series we report loss of two kidney allografts secondary to vascular complications due to Candida albicans. Both recipients received grafts from a common donor, in whom Candida bacteremia in the donor was not apparent at the time of organ acceptance but became apparent on delayed cultures.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3504265PMC
http://dx.doi.org/10.1155/2012/364735DOI Listing

Publication Analysis

Top Keywords

allografts secondary
8
vascular complications
8
donor infections
8
loss renal
4
renal allografts
4
secondary candida
4
candida vascular
4
complications recipients
4
donor
4
recipients donor
4

Similar Publications

Background: Graft loss is a major health concern for kidney transplant (KTx) recipients. It is of clinical interest to develop a prognostic model for both graft function, quantified by estimated glomerular filtration rate (eGFR), and the risk of graft failure. Additionally, the model should be dynamic in the sense that it adapts to accumulating longitudinal information, including time-varying at-risk population, predictor-outcome association, and clinical history.

View Article and Find Full Text PDF

Objective: Popliteal artery injury is a rare but serious complication of arthroscopic knee surgery. The absence of comprehensive data and standardized guidelines underscores the urgent need for further investigation. This study examines the incidence, risk factors, management strategies, and long-term outcomes of popliteal artery injury in the context of arthroscopic knee procedures.

View Article and Find Full Text PDF

We report our hospital-based experience in management strategies and outcomes for pediatric extremity vascular trauma at a major trauma center. A retrospective chart review was conducted on patients under 18 with extremity vascular injuries who had surgery between May 2021 and February 2023. Among 46 children, 16 (34.

View Article and Find Full Text PDF

renal transplant carcinoma, especially in the context of bilateral renal carcinoma, is rare and often presents as small, low-grade papillary renal cell carcinoma (RCC). There is currently no consensus or effective treatment for advanced metastatic RCC after kidney transplantation. A 40-year-old man developed renal transplant carcinoma with venous thrombus and lung metastases 13 years after transplantation.

View Article and Find Full Text PDF

Letermovir for prevention of recurrent CMV in high-risk allogeneic hematopoietic cell transplant (HCT) recipients.

Transplant Cell Ther

December 2024

Infectious Diseases Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, NY. Electronic address:

Background: We evaluated letermovir (LTV) for secondary prophylaxis for cytomegalovirus (CMV) in allogeneic hematopoietic cell transplant recipients (HCT) at high-risk for CMV recurrence.

Methods: Open-label study conducted at Memorial Sloan Kettering Cancer Center and the University of Minnesota. Patients with clinically significant CMV infection (cs-CMVi) and ≥1 high-risk criteria for CMV who achieved viral suppression with standard CMV antivirals, received letermovir (LTV) secondary prophylaxis for up to 14 weeks.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!